Search

[No abstract available], Funding Agencies|Flinders University; RU, Radboud Universiteit; NIU, Northern Illinois University; University of Nottingham; Universität zu Köln; Charité – Universitätsmedizin Berlin; SLU, Saint Louis University; TU/e, Technische Universiteit Eindhoven; University of Leeds; IUPUI, Indiana University-Purdue University Indianapolis; UiT, Universitetet i Tromsø; EUR, Erasmus Universiteit Rotterdam; UvT, Universiteit van Tilburg; University of Oxford; UNIL, Université de Lausanne; SEBM, Society for Experimental Biology and Medicine; NYU, New York University; UiT, Universitetet i Tromsø; RWTH Aachen University; KU Leuven; Universität Bielefeld; University of Louisiana at Lafayette; UA, University of Arkansas; Genentech Foundation for Biomedical Sciences; University of Bristol; UV, University of Virginia; City of Mobile; Université de Fribourg; Universiteit Gent; Yale University; VT, Virginia Polytechnic Institute and State University; DIBS, Duke Institute for Brain Sciences, Duke University; UCB UK; University of Leeds; BIBS, Brown Institute for Brain Science; UU, Universiteit Utrecht; Keele University; HRD, Division of Human Resource Development; WVU, West Virginia University; King’s College London; NTU, Nottingham Trent University; Rijksuniversiteit Groningen; KACST, King Abdulaziz City for Science and Technology; University of Edinburgh; UCONN, University of Connecticut; University of Kent; University of Cambridge; UNLV, University of Nevada, Las Vegas; Universiteit Leiden; UBC, University of British Columbia; HGS, Human Genome Sciences; AV CR, Akademie Ved Ceské Republiky; IUPUI, Indiana University-Purdue University Indianapolis; UK, University of Kentucky; University of Texas at Austin; DRS, Dahlem Research School, Freie Universität Berlin; Bangor University; RAND Corporation; University of Glasgow; University of Chester; CONICET, Consejo Nacional de Investigaciones Científicas y Técnicas; Massey University; UC, University of California; NIH, National Institutes

Contains fulltext : 174700.pdf (publisher's version ) (Open Access), Vaccination of infants with bacillus Calmette-Guerin (BCG) activates both the innate and adaptive arms of the immune response. The antimycobacterial effects of these responses most likely account for the ability of BCG to protect against childhood forms of tuberculosis (TB). There is also evidence for a heterologous protective effect of BCG vaccination against TB-unrelated mortality in low birth weight infants. A possible mechanism of action of this effect, the induction of trained innate immunity, has been demonstrated when cells from BCG-vaccinated adults are restimulated in vitro with non-related microbial stimuli. Our aim was to examine an extensive panel of secreted immune biomarkers to characterize the profile of trained innate immunity in infants. Stimulation of whole blood for 48 h was performed 4 months after BCG vaccination, or in control unvaccinated infants. Stimulants were lipopolysaccharide; Pam3Cys (P3C); heat-killed Candida albicans, Staphylococcus aureus, Escherichia coli, and a lysate of Mycobacterium tuberculosis. Culture supernatants were tested for secreted cytokines and chemokines by 42-plex bead array and monocytes and natural killer (NK) cells assessed for expression of activation markers by flow cytometry. BCG-vaccinated infants displayed increases in 11 cytokines and chemokines in response to different non-specific innate immunity stimuli: epidermal growth factor (EGF); eotaxin; IL-6; IL-7; IL-8; IL-10; IL-12p40; monocyte chemotactic protein-3; macrophage inflammatory protein-1alpha; soluble CD40 ligand and platelet-derived growth factor (PDGF)-AB/BB. Although each stimulant induced a distinct response profile, three analytes, EGF, IL-6, and PDGF-AB/BB, were commonly higher after stimulation with Pam3Cys, C. albicans, and S. aureus. Conversely, certain cytokines such as interferon gamma-inducible protein-10, IL-2, IL-13, IL-17, GM-CSF, and GRO were suppressed in BCG-vaccinated infants, while no increases in TNFalpha or IL-1beta production w

Aims: The use of tamoxifen and raloxifene as preventive therapy for women at increased risk of breast cancer was approved by the National Institute for Health and Care Excellence (NICE) in 2013. We undertook a qualitative investigation to investigate the factors affecting the implementation of preventive therapy within the UK. Methods: We recruited general practitioners (GPs) (n = 10) and clinicians working in family history or clinical genetics settings (FHCG clinicians) (n = 15) to participate in semi-structured interviews. Data were coded thematically within the Consolidated Framework for Implementation Research. Results: FHCG clinicians focussed on the perceived lack of benefit of preventive therapy and difficulties interpreting the NICE guidelines. FHCG clinicians felt poorly informed about preventive therapy, and this discouraged patient discussions on the topic. GPs were unfamiliar with the concept of preventive therapy, and were not aware that they may be asked to prescribe it for high-risk women. GPs were reluctant to initiate therapy because it is not licensed, but were willing to continue a prescription if it had been started in secondary or tertiary care. Conclusions: Barriers to implementing preventive therapy within routine clinical practice are common and could be addressed by engaging all stakeholders during the development of policy documents.

Item does not contain fulltext

Eleocharis obtusetrigona (Lindl. & Nees) Steud., previously known only from South America, is recorded here for southeastern United States, Mexico and Central America. A description of the species is presented, as well as a key to separate E. obtusetrigona from other robust species of subgenus Limnochloa with which it has been confused., Eleocharis obtusetrigona (Lindl. & Nees) Steud., conocido previamente de Sudamérica, es registrado aquí para el sureste de los Estados Unidos, México y Centroamérica. Se presenta una descripción de la especie, así como una clave para especies robustas de Eleocharis subgénero Limnochloa con las cuales E. obtusetrigona ha sido confundida.